Aisthesis Medical, through its innovative product VIOSync, is at the forefront of transforming acute care with AI technology. VIOSync proactively predicts sepsis and hypotension, two critical health risks affecting millions globally. Integrating seamlessly with wearable devices, bedside monitors and EHRs, VIOSync creates an extensive digital twin for each patient, employing multimodal data for personalized, explainable AI analytics. VIOSync offers a new paradigm in patient monitoring and not only alerts clinicians about potential patient deterioration but also guides them in making timely, informed decisions. VIOSync stands out for its commitment to improving patient outcomes, reducing hospital stays, and cutting healthcare costs, particularly in critical and undermonitored care areas like surgical wards and emergency departments.